Girentuximab MMAE Antibody
Girentuximab-MMAE is an anti-CAIX antibody-drug conjugate (ADC) produced in CHO cells, comprising a human IgG1 heavy chain and a kappa light chain with a predicted molecular weight of 144.62 kDa. This research tool is utilized in preclinical studies for investigating targeted therapies against CAIX-expressing cancers in both in vitro and in vivo models.
Product Specifications
Target
Others
Conjugation
Unconjugated
Molecular Weight
150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog